ClinicalTrials.gov term: Spondylitis, Ankylosing
Ankylosing Spondylitis clinical trials
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
13 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 10 with minor changes only.
- Minor: XRPMS · Korean Post-marketing Surveillance for Xeljanz XR Trial completed
- Minor: Tulisokibart (MK-7240) · Radiographic Axial Spondyloarthritis (MK-7240-013) Enrollment closed, study ongoing
- Minor: Surface Topography and Radiographic Spinal Damage in Radiographic Axial Spondyloarthritis Study completion moved earlier from Aug 20, 2027 to Jun 20, 2027
-
Minor: 3 trials marked Unknown by the registry's verification sweep Changed
- Minor: Cardiovascular Disease Risk Factors and Healthy Lifestyle Behaviours · Ankylosing Spondylitis Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: IL17 Inhibitor in Comparison With Anti-TNF · Ankylosing Spondylitis Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis Changed Registry marked status Unknown (sponsor has not verified the record since May 2024); last known: Active, Not Recruiting
- Minor: Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries Trial completed
- Minor: Neuropathic Spinal Pain in Ankylosing Spondylitis Study completion pushed from Dec 2, 2026 to May 2, 2027
- Notable: Ia Study of MST-931 in Healthy Adult Subjects Recruitment opened
- Notable: Pain Phenotyping of Rheumatic Diseases - An Observational Study Recruitment opened
- Notable: RENEW Intervention for Axial Spondyloarthritis Recruitment opened
- Minor: Treatment Effectiveness · axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor Primary and study completion pushed from Mar 2027 to Jul 31, 2027
- Minor: Biomarkers in Ankylosing Spondylitis Trial completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New sponsor entrants, last 90 days sponsors with their first trial in this area
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-11-18 | NCT07946055 Scapular Mobilization Added to Conventional Exercise in Ankylosing Spondylitis | Izmir Bakircay University new | |
| 2026-11-06 | NCT07920861 A Study of HB0017 Injection in Healthy Volunteers to Evaluate Safety and Tolerability of… | Huabo Biopharm Co., Ltd. new | Phase 1 |
| 2026-11-04 | NCT07915544 A Study of GKL-006Allo Injection in Patients With Ankylosing Spondylitis | Beijing Gene Key Life Technology Co., Ltd new | Phase 1 |
| 2026-10-29 | NCT07903493 Phase Ia Study of MST-931 in Healthy Adult Subjects | Mabsoft Therapeutics (Shanghai) Co., Ltd. new | Phase 1 |
| 2026-10-26 | NCT07894497 Ivarmacitinib With or Without Celecoxib for Ankylosing Spondylitis | Peking University Third Hospital new | Phase 4 |
| 2026-10-23 | NCT07891507 Nurse-Led Exercise Program for Older Adults With Ankylosing Spondylitis | Mansoura University new | |
| 2026-10-16 | NCT07879157 Posture Exercises in Ankylosing Spondylitis | Mustafa Akça new | |
| 2026-10-02 | NCT07855393 Surface Topography and Radiographic Spinal Damage in Radiographic Axial Spondyloarthritis | Ankara Etlik City Hospital new | |
| 2026-09-29 | NCT07847320 Controlled Reduction of AO Spine B3 Fractures in Ankylosing Spinal Disorders Using an… | Diakonie-Klinikum Stuttgart new | |
| 2026-09-29 | NCT07847879 Effects of Pulmonary Rehabilitation Exercises in Patients With Axial Spondyloarthritis | Sisli Hamidiye Etfal Training and Research Hospital new |
Active trials by phase
| Phase 1 | 7 | |
| Phase 1/2 | 3 | |
| Phase 2 | 8 | |
| Phase 2/3 | 3 | |
| Phase 3 | 9 | |
| Phase 4 | 14 |
Not charted: 96 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Top sponsors by active trials in this area
Assiut University (7) · China-Japan Friendship Hospital (5) · Assistance Publique - Hôpitaux de Paris (4) · Novartis Pharmaceuticals (3) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (3) · The Danish Center for Expertise in Rheumatology (3) · Biocad (2) · Bozyaka Training and Research Hospital (2) · CARE ARTHRITIS LTD. (2) · Charite University, Berlin, Germany (2)
Get alerts when Ankylosing Spondylitis trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.